These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38759304)

  • 21. Evaluation of spike protein antigens for SARS-CoV-2 serology.
    Jagtap S; K R; Valloly P; Sharma R; Maurya S; Gaigore A; Ardhya C; Biligi DS; Desiraju BK; Natchu UCM; Saini DK; Roy R
    J Virol Methods; 2021 Oct; 296():114222. PubMed ID: 34197839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients.
    Yang L; Xu Q; Yang B; Li J; Dong R; Da J; Ye Z; Xu Y; Zhou H; Zhang X; Liu L; Zha Y; Yu F
    BMC Microbiol; 2021 Dec; 21(1):351. PubMed ID: 34922455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A qualitative IgG ELISA for detection of SARS-CoV-2-specific antibodies in Syrian hamster serum samples.
    Shete A; Mohandas S; Jain R; Yadav PD
    STAR Protoc; 2021 Jun; 2(2):100573. PubMed ID: 33997801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS.
    Saijo M; Ogino T; Taguchi F; Fukushi S; Mizutani T; Notomi T; Kanda H; Minekawa H; Matsuyama S; Long HT; Hanh NT; Kurane I; Tashiro M; Morikawa S
    J Virol Methods; 2005 May; 125(2):181-6. PubMed ID: 15794988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies.
    Solastie A; Virta C; Haveri A; Ekström N; Kantele A; Miettinen S; Lempainen J; Jalkanen P; Kakkola L; Dub T; Julkunen I; Melin M
    Microbiol Spectr; 2021 Dec; 9(3):e0113121. PubMed ID: 34787485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
    Jalkanen P; Pasternack A; Maljanen S; Melén K; Kolehmainen P; Huttunen M; Lundberg R; Tripathi L; Khan H; Ritvos MA; Naves R; Haveri A; Österlund P; Kuivanen S; Jääskeläinen AJ; Kurkela S; Lappalainen M; Rantasärkkä K; Vuorinen T; Hytönen J; Waris M; Tauriainen S; Ritvos O; Kakkola L; Julkunen I
    J Infect Dis; 2021 Jul; 224(2):218-228. PubMed ID: 33905505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome.
    Butt J; Murugan R; Hippchen T; Olberg S; van Straaten M; Wardemann H; Stebbins E; Kräusslich HG; Bartenschlager R; Brenner H; Laketa V; Schöttker B; Müller B; Merle U; Waterboer T
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.
    Aleshkin AV; Novikova LI; Bochkareva SS; Kombarova SY; Lebedin YS; Vorob'ev AM; Mekhtiev ER; Zul'karneev ER; Laishevtsev AI; Karaulov AV
    Bull Exp Biol Med; 2021 May; 171(2):230-233. PubMed ID: 34173107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
    Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
    Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
    Yue L; Cao H; Xie T; Long R; Li H; Yang T; Yan M; Xie Z
    J Med Virol; 2021 Mar; 93(3):1732-1738. PubMed ID: 32965677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
    Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
    mBio; 2021 May; 12(3):. PubMed ID: 34006662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saliva SARS-CoV-2 Antibody Prevalence in Children.
    Keuning MW; Grobben M; de Groen AC; Berman-de Jong EP; Bijlsma MW; Cohen S; Felderhof M; de Groof F; Molanus D; Oeij N; Rijpert M; van Eijk HWM; Koen G; van der Straten K; Oomen M; Visser R; Linty F; Steenhuis M; Vidarsson G; Rispens T; Plötz FB; van Gils MJ; Pajkrt D
    Microbiol Spectr; 2021 Oct; 9(2):e0073121. PubMed ID: 34523985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.
    Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19.
    Khan WH; Khan N; Mishra A; Gupta S; Bansode V; Mehta D; Bhambure R; Ansari MA; Das S; Rathore AS
    Int J Biol Macromol; 2022 Mar; 200():428-437. PubMed ID: 35051498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological Testing for COVID-19, Immunological Surveillance, and Exploration of Protective Antibodies.
    Peroni LA; Toscaro JM; Canateli C; Tonoli CCC; de Olivera RR; Benedetti CE; Coimbra LD; Pereira AB; Marques RE; Proença-Modena JL; Lima GC; Viana R; Borges JB; Lin-Wang HT; Abboud CS; Gun C; Franchini KG; Bajgelman MC
    Front Immunol; 2021; 12():635701. PubMed ID: 34489923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.